Search Results
Dr. Rathkopf on Investigative Agents in Prostate Cancer
Dr. Rathkopf on Mitigating AR Resistance in Prostate Cancer
Dr. Rathkopf on AR-V7 Biomarker in Prostate Cancer
Extraordinary Patient Care
Dr. Stein on Trials Investigating Biomarkers in Prostate Cancer
2017 MSK Alumni Conference - Dana E. Rathkopf, MD
Decisions on Choosing LHRH Agonists for Treating Prostate Cancer
Dr. Stacy Loeb on Considerations for Screening in Prostate Cancer
Current developments in castration-resistant prostate cancer therapies
Dr. Marc Bjurlin on Predictive Models for Prostate Cancer Risk
Dr. Tagawa on Next Steps for Taxanes in Prostate Cancer
The Future of Prostate Cancer Research and Treatment